BridgeMD
Tests treatment safety and results for Subarachnoid Hemorrhage, Aneurysmal
Official title Safety , Feasibility and Preliminary Efficacy of Remote Ischemic Conditioning in Patients With Aneurysmal Subarachnoid Hemorrhage After Aneurysm Clipping
ClinicalTrials.gov ID: NCT06819657
What this study is testing
- What it's testing
- This study was designed to evaluate the safety and efficacy of remote ischemic conditioning (RIC) in patients with aneurysmal subarachnoid hemorrhage (aSAH) following surgical clipping. Aneurysmal subarachnoid hemorrhage is a life-threatening condition that occurs when a cerebral aneurysm ruptures, causing bleeding into the subarachnoid space.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- Imaging examination confirmed aneurysmal subarachnoid hemorrhage.
- Responsible aneurysms received craniotomy clipping within 24 hours.
- 18≤ age ≤80 years old.
- Informed consent of the participant or legally authorized representative
You likely can't join if
- Patients with other types of cerebral hemorrhage.
- Prior neurological impairment (mRS Score \>1) or mental illness may confuse neurological or functional assessment.
- Severe comorbidities with a life expectancy of less than 90 days.
- Refractory hypertension (systolic blood pressure 180\>mmHg or diastolic blood pressure 110\>mmHg).
- RIC contraindications: severe soft tissue injury of lower limbs.
- Simultaneously participate in another research program to study a different experimental therapy.
See the full eligibility criteria
- Imaging examination confirmed aneurysmal subarachnoid hemorrhage.
- Responsible aneurysms received craniotomy clipping within 24 hours.
- 18≤ age ≤80 years old.
- Informed consent of the participant or legally authorized representative
- Patients with other types of cerebral hemorrhage.
- Prior neurological impairment (mRS Score \>1) or mental illness may confuse neurological or functional assessment.
- Severe comorbidities with a life expectancy of less than 90 days.
- Refractory hypertension (systolic blood pressure 180\>mmHg or diastolic blood pressure 110\>mmHg).
- RIC contraindications: severe soft tissue injury of lower limbs.
- Simultaneously participate in another research program to study a different experimental therapy.
- Any condition that the investigator believes may increase the patient's risk.
The study team makes the final eligibility decision.
Where it's taking place
- Beijing, Beijing Municipality, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Beijing, Beijing Municipality, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.